Major depressive disorder has a major impact on ability to function and has a negative impact on quality of life. MDD is a leading cause of disability throughout the world and is a major contributor to the overall global burden of disease.
Treatment outcomes can be poor, with less than half of those treated achieving remission. A failure to regain pre-morbid level of function is common and impacts both the person and their love ones.
This program includes two case-based modules, the first of which will review treatment initiation and optimization in MDD based on the CANMAT guidelines, with a focus on the advantages and disadvantages of different treatment alternatives.The second case-based module will review the evidence supporting different management options for optimizing treatment of MDD and will review the atypical antipsychotic treatment options for adjunctive therapy in MDD.